Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Feb;39(2):736-41.
doi: 10.1128/iai.39.2.736-741.1983.

Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes

Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes

C Dahlgren et al. Infect Immun. 1983 Feb.

Abstract

When polymorphonuclear leukocytes (PMNL) and soluble or particulate matter interact, the cells produce chemiluminescence, linked to activation of the oxidative metabolism of the cells. PMNL isolated from a patient with a myeloperoxidase deficiency were found to produce almost no luminol-dependent chemiluminescence, despite a pronounced production of superoxide anions (O2-). The chemotactic peptide formylmethionyl-leucyl-phenylalanine induced a two-peak chemiluminescence response in control PMNL. The response was modified, both in magnitude and in time-course, when the cells were incubated at 22 degrees C for 120 min. Addition of purified myeloperoxidase to the PMNL lacking this enzyme, before stimulus addition, resulted in a chemiluminescence response. In the response to formylmethionyl-leucyl-phenylalanine, only one peak, corresponding to the initial peak of control PMNL, was found. This indicated that luminol-dependent chemiluminescence is dependent on and directly related to the presence of myeloperoxidase in PMNL and that both intra- and extracellularly located myeloperoxidase has to be taken into account when interpreting the cellular response assayed as chemiluminescence.

PubMed Disclaimer

References

    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed
    1. Biochem Biophys Res Commun. 1972 May 26;47(4):679-84 - PubMed
    1. Scand J Haematol. 1972;9(5):483-91 - PubMed
    1. Infect Immun. 1974 Jun;9(6):1051-6 - PubMed
    1. J Clin Invest. 1976 Jul;58(1):50-60 - PubMed

Publication types

MeSH terms